BETTERLIFE PHARMA (BETRF, $0.07) was a top loser over the last three months, falling -2 to $0.07 per share. A.I.dvisor analyzed 841 stocks in the Biotechnology Industry for the 3-month period ending May 8, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.